CAS: 1596-67-4; L-Thyronine

该化合物是一种高纯度合成甲状腺激素模拟物,通常用于生化和制药研究,其主要优势在于其纯度稳定(95%),确保甲状腺激素受体,代谢途径和内分泌系统调制等研究的可靠性能.该化合物适合体外和体外应用,包括受体约束试验和机械学研究.其定义明确的化学结构允许在实验环境中精确使用和再复制.L-Thyronine通常作为浸泡粉提供,增强稳定性和处理便利性.建议在受控制条件下适当储存,以保持其完整性,供长期使用.

结构式图片

相似化合物

1034-10-2 1213135-25-1 1354485-04-3

上下游产品

CAS号51-48-9 左旋甲状腺素 | CAS号1041-01-6 3,5-二碘-L-甲状腺素 | CAS号3483-82-7 N-苯甲酰-L-酪氨酸乙酯 | CAS号53663-23-3 1,2,3-三碘-5-硝基苯 | CAS号949-67-7 L-酪氨酸乙酯

合成工艺路线路线简述

    甲状腺素置于sodium Tetrahydroborate,C10H8Ste,1,4-二巯基-2,3-丁二醇体系中,用 Aq. Phosphate Buffer 用作溶剂,化学反应 0.5H,反应生成L-甲状腺氨酸
    参考文献:硫属元素取代对甲状腺激素脱碘酶模拟物的显著作用
    标题:硫属元素取代对甲状腺激素脱碘酶模拟物的显著作用
    摘要:碘甲状腺素脱碘酶是通过催化甲状腺素(t4)的区域选择性脱碘作用来调节甲状腺激素稳态的硒酶.合成的脱碘酶模拟物不仅对于了解酶催化的机理很重要,而且对于开发治疗剂也很重要,因为甲状腺激素水平异常会影响不同疾病的发生,例如缺氧,心肌梗塞,危重疾病,神经元缺血,组织损伤和癌症.本文描述的是,通过碲置换一系列脱碘酶模拟物中的硫/硒原子显着改变了对t4的反应性和区域选择性.
    Doi:10.1002/anie.201502762

    海关参考信息

    专利信息


    专利号:US-2022243244-A1
    优先权日:2019-10-10
    标 题 :Compositions and methods for in vivo synthesis of unnatural polypeptides
    发明人:ROMESBERG FLOYD E; FISCHER EMIL C; HASHIMOTO KOJI; FELDMAN AARON W; DIEN VIVIAN T; ZHANG YORKE
    权利人:SCRIPPS RESEARCH INST
    摘要:Disclosed herein are compositions, methods, and kits for a cell incorporating unnatural amino acids into an unnatural polypeptide. Also disclosed herein are compositions, methods, and kits for increasing activity and yield of the unnatural polypeptide synthesized by the cell.

    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2025084410-A1
    优先权日:2015-01-12
    标 题:Incorporation of unnatural nucleotides and methods thereof
    发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
    权利人:SYNTHORX INC
    摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

    专利号:WO-2024200180-A1
    优先权日:2023-03-29
    标题 :Novel l-thyroxine radioiodine label and process for production thereof
    发明人:DREWES BIRTE; BIER DIRK; HOLSCHBACH MARCUS; HUMPERT SWEN; SCHNEIDER DANIELA; NEUMAIER BERND
    权利人:FORSCHUNGSZENTRUM JUELICH GMBH
    摘要:The present invention relates to a multistage synthesis process proceeding from 3,5-diiodo-L-thyronine for synthesis of an L-thyroxine radiolabelled in the 3 position on the inner ring. The present invention further relates to specific intermediates in the synthesis process of the invention, to the radiolabels obtainable and to the use of the radiolabels in nuclear-medical imaging methods and in in vitro and ex vivo applications.

    专利号:US-8183409-B2
    优先权日:2004-05-06
    标题:High yield and rapid synthesis methods for producing metallo-organic salts
    发明人:CHRISTGAU STEPHAN; ANDERSEN JENS E T
    权利人:CHRISTGAU STEPHAN; ANDERSEN JENS E T; OSTEOLOGIX AS
    摘要:A new method for preparing salts of metal cations and organic acids, especially divalent salts of alkaline earth metal ions from group II of the periodic system and carboxylic acids. The method comprising the use of a high temperature (about 90° or more) and, optionally. high pressure, in order to obtain a higher yield, purity and faster reaction speed than obtained with known synthesis methods. In particular, the present invention relates to the production of strontium salts of carboxylic acids. Novel strontium salts are also provided by the present method.
    成都百易源生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.byybio.com
    电话: 13402890778👤
    📞成都百易源生物技术有限公司 ⚠️参考联系方式

    销售电话:13402890778
    邮箱:1120021438@qq.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Elina Koivisto, Et Al. Characterization Of The Regulatory Mechanisms Of Activating Transcription Factor 3 By Hypertrophic Stimuli In Rat Cardiomyocytes. Plos One. 2014 Aug 19;9(8):E105168.
    [参考文献]: F Oltulu, Et Al. Immunoexpressions Of Embryonic And Nonembryonic Stem Cell Markers (Nanog, Thy-1, C-Kit) And Cellular Connections (Connexin 43 And Occludin) On Testicular Tissue In Thyrotoxicosis Rat Model. Hum Exp Toxicol. 2015 Jun;34(6):601-11.
    [参考文献]: G Almer, Et Al. Increased Levels Of The Pro-Inflammatory Prostaglandin Pge2 In Csf From Als Patients. Neurology. 2002 Apr 23;58(8):1277-9.
    [参考文献]: I J Chopra, Et Al. A Radioimmunoassay For Measurement Of Thyroxine Sulfate. J Clin Endocrinol Metab. 1993 Jan;76(1):145-50.
    [参考文献]: J P Malin, Et Al. T4, T3 And Rt3 Levels In Serum And Cerebrospinal Fluid Of Patients With Amyotrophic Lateral Sclerosis. J Neurol. 1989 Jan;236(1):57-9.

    合成参考文献


    参考文献:10.1212/wnl.58.8.1277
    摘要:Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology. 2002 Apr 23;58(8):1277–9. doi: 10.1212/wnl.58.8.1277.
    参考文献:10.3109/13813459408996096
    摘要:Morell M, Fernández-guillién FJ, López-garcía JM. Levels of L-T3 in maternal and foetal compartments following experimental modifications of the maternal thyroid state in rats. Archives Internationales de Physiologie, de Biochimie et de Biophysique. 1994 Jan;102(1):1–3. doi: 10.3109/13813459408996096.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知